Home > Health News > African scientists begin trial on malaria vaccine

African scientists begin trial on malaria vaccine

labtechScientists in Africa have begun trials of a malaria vaccine which, if successful, could save millions of lives on the continent and around the world.

The mosquirix vaccine also known as RDSS is being tested in Africa’s biggest ever clinical trial, spanning seven nations, and involving over 16thousand children. Reports say more than five thousand have already undergone preliminary trials since testing began in 2003.

The vaccine is the result of a partnership between GlaxoSmithKline the British drug manufacturer, and US-based path Malaria Vaccine Imitative which is funded by the Bill and Melinda Gates Foundation along with clinics and research centres in Africa.

Source: GBC

Advertisements
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: